Conditional survival (CS) for patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy (TT): Results from the international mRCC database consortium.
Toni K. Choueiri
Disclosure not yet available
Wanling Xie
Disclosure not yet available
Lauren Christine Harshman
Disclosure not yet available
Georg A. Bjarnason
Disclosure not yet available
Jennifer J. Knox
Disclosure not yet available
Mary J. MacKenzie
Disclosure not yet available
Lori Wood
Disclosure not yet available
Ulka N. Vaishampayan
Disclosure not yet available
Min-Han Tan
Disclosure not yet available
Sun Young Rha
Disclosure not yet available
Frede Donskov
Disclosure not yet available
Neeraj Agarwal
Disclosure not yet available
Christian K. Kollmannsberger
Disclosure not yet available
Scott A. North
Disclosure not yet available
Brian I. Rini
Disclosure not yet available
Daniel Yick Chin Heng
Disclosure not yet available